Parsippany-based Actavis Inc. announced today it will acquire Warner Chilcott PLC in a $5 billion stock swap that’s expected to create a specialty pharmaceuticals company with about $11 million in annual revenue.
Actavis said it will swap 0.16 of a share for each Chilcott share, valuing the Chilcott shares at about $20.08 each. The deal is expected to close by the end of the year.
The new company, Actavis PLC, will be led by the current Actavis leadership team, the company said.
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy